A study led by Johns Hopkins describes a method for automating slow, inaccurate manual chart review when searching for signs of misdiagnosis.
The company estimates that the quality control issue resulted in between two and 15 patients getting a false negative result.
DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.
Regulators have proposed banning Theranos CEO from owning or operating any lab for two years, the Wall Street Journal reports.
Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.
NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.
A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.
In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.